Neurogene Inc. (NGNE)
NASDAQ: NGNE · IEX Real-Time Price · USD
50.90
+1.64 (3.33%)
At close: Mar 28, 2024, 4:00 PM
49.75
-1.15 (-2.26%)
After-hours: Mar 28, 2024, 5:55 PM EDT
Neurogene Market Cap
Neurogene has a market cap or net worth of $406.51 million as of March 28, 2024. Its market cap has increased by 1,321.37% in one year.
Market Cap
406.51M
Enterprise Value
225.10M
1-Year Change
1,321.37%
Ranking
Category
Stock Price
$50.90
Market Cap Chart
Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $406.51M, an increase of 256.28%. That is a compound annual growth rate of 13.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 633.10M | -0.39% |
Mar 26, 2024 | 635.60M | 0.86% |
Mar 25, 2024 | 630.20M | -1.70% |
Mar 22, 2024 | 641.10M | 1.34% |
Mar 21, 2024 | 632.60M | 9.86% |
Mar 20, 2024 | 575.80M | -0.59% |
Mar 19, 2024 | 579.20M | 20.02% |
Mar 18, 2024 | 482.60M | 447.17% |
Mar 15, 2024 | 88.20M | 8.62% |
Mar 14, 2024 | 81.20M | -4.13% |
Mar 13, 2024 | 84.70M | -0.82% |
Mar 12, 2024 | 85.40M | -0.23% |
Mar 11, 2024 | 85.60M | -2.17% |
Mar 8, 2024 | 87.50M | -3.74% |
Mar 7, 2024 | 90.90M | 1.91% |
Mar 6, 2024 | 89.20M | 1.94% |
Mar 5, 2024 | 87.50M | -3.42% |
Mar 4, 2024 | 90.60M | 20.48% |
Mar 1, 2024 | 75.20M | 3.01% |
Feb 29, 2024 | 73.00M | 1.25% |
Feb 28, 2024 | 72.10M | -5.38% |
Feb 27, 2024 | 76.20M | 6.57% |
Feb 26, 2024 | 71.50M | 0.99% |
Feb 23, 2024 | 70.80M | -0.56% |
Feb 22, 2024 | 71.20M | 1.71% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Lexeo Therapeutics | 410.34M |
Zynex | 409.85M |
MeiraGTx Holdings | 408.42M |
Clover Health Investments | 406.73M |
Harrow Health | 406.67M |
iTeos Therapeutics | 402.34M |
ESSA Pharma | 399.91M |
Aquestive Therapeutics | 394.06M |